接受抗甲状腺药物治疗的格雷夫斯病患者的血清抗髓过氧化物酶抗中性粒细胞胞浆抗体（MPO-ANCA） - Suppr | 超能文献

Serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease receiving anti-thyroid medication.

作者信息

Ashizawa Kiyoto, Eguchi Katsumi

出版信息

Intern Med. 2003 Jun;42(6):463-4. doi: 10.2169/internalmedicine.42.463.

DOI:10.2169/internalmedicine.42.463

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease receiving anti-thyroid medication.接受抗甲状腺药物治疗的格雷夫斯病患者的血清抗髓过氧化物酶抗中性粒细胞胞浆抗体（MPO-ANCA）

Intern Med. 2003 Jun;42(6):463-4. doi: 10.2169/internalmedicine.42.463.

2

Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.丙硫氧嘧啶治疗的格雷夫斯病患者中髓过氧化物酶抗中性粒细胞胞浆抗体（MPO-ANCA）的出现频率及MPO-ANCA与临床表现的关系。

Clin Endocrinol (Oxf). 2001 May;54(5):651-4. doi: 10.1046/j.1365-2265.2001.01282.x.

3

Propylthiouracil (PTU)-induced vasculitis associated with antineutrophil antibody against myeloperoxidase (MPO-ANCA).丙硫氧嘧啶（PTU）诱发的血管炎，与抗髓过氧化物酶抗中性粒细胞抗体（MPO-ANCA）相关。

Intern Med. 2003 Jun;42(6):529-33. doi: 10.2169/internalmedicine.42.529.

4

Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.儿童期发病的格雷夫斯病患者中丙硫氧嘧啶相关的抗中性粒细胞胞浆抗体（ANCA）

J Pediatr Endocrinol Metab. 2008 Jun;21(6):539-43.

5

Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.丙硫氧嘧啶诱发血管炎患者血清中抗髓过氧化物酶抗体亲和力和滴度的随访

Clin Endocrinol (Oxf). 2007 Apr;66(4):543-7. doi: 10.1111/j.1365-2265.2007.02770.x.

6

Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.格雷夫斯病患者中丙硫氧嘧啶和卡比马唑相关抗中性粒细胞胞浆抗体（ANCA）

Clin Endocrinol (Oxf). 2004 Jun;60(6):671-5. doi: 10.1111/j.1365-2265.2004.02029.x.

7

Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.在一些格雷夫斯病患者中，丙硫氧嘧啶治疗与抗中性粒细胞胞浆抗体的出现有关。

Thyroid. 2000 Jul;10(7):595-9. doi: 10.1089/thy.2000.10.595.

8

High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.在接受丙硫氧嘧啶治疗的儿童期发病的格雷夫斯病中抗中性粒细胞胞浆抗体阳性的高患病率。

J Clin Endocrinol Metab. 2000 Nov;85(11):4270-3. doi: 10.1210/jcem.85.11.7000.

9

Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole.接受丙硫氧嘧啶和甲巯咪唑治疗的格雷夫斯病患者血清抗髓过氧化物酶抗中性粒细胞胞浆抗体（MPO-ANCA）的患病率。

Endocr J. 2002 Jun;49(3):329-34. doi: 10.1507/endocrj.49.329.

10

[Antineutrophil cytoplasmic antibody (Anca)-associated autoimmune disease induced by propylthiouracil].[丙硫氧嘧啶诱发的抗中性粒细胞胞浆抗体（ANCA）相关自身免疫性疾病]

Arq Bras Endocrinol Metabol. 2007 Feb;51(1):136-41. doi: 10.1590/s0004-27302007000100022.